App-Quantinova.ai

Risk of HER2-positive breast cancer among germline CHEK2 mutation carriers with breast cancer.

Chethan Ramamurthy - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Genome-wide association study (GWAS) of response to androgen deprivation therapy (ADT) and survival in metastatic prostate cancer (PCa).

Mark Pomerantz - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

Androgen Tear

Comprehensive population-wide detection of Lynch syndrome in Iceland.

Sigurdis Haraldsdottir - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lynch syndrome

N/A

The identification of novel genetic risk loci in uveal melanoma.

Tomas Kirchhoff - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Uveal melanoma

N/A

Genomic complexity and prognosis of renal medullary carcinoma.

Hina Khan - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal medullary carcinoma

N/A

Gender bias: Underdiagnosing hereditary cancer in men with prostate cancer.

Lauren Bowling - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

Impact of aspirin use on the incidence of head and neck cancers: A systematic review and meta-analysis.

Prakash C. Neupane - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Squamous cell carcinoma of the head and neck

Aspirin

Breast cancer chemoprevention in primary care: Assessing readiness for change.

Haiyun Wang - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Methadone hydrochloride

Change in prostate biopsy outcomes and costs of care for prostate cancer in underserved population after changes in USPSTF guidelines.

Amit Mohan Algotar - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: Colorectal cancer survival by trial arm.

Maryam Doroudi - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

The opportunity cost (OC) of low adherence with screening (scr) recommendations for colorectal cancer (CRC).

Afsaneh Barzi - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

A pilot randomised controlled trial examining the feasibility, acceptability and impact of giving information on personalised genomic risk of melanoma to the public, for motivating preventive behaviours.

Anne E. Cust - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Melanoma

N/A

Application of the 2015 American Cancer Society screening mammography guidelines: Risk assessment for women ages 40-44.

Jennifer Kay Plichta - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Use and adherence to breast cancer risk-reduction agents: A population-based study.

Mariana Chavez-Mac Gregor - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Raloxifene

Natural language processing (NLP) software use in the discovery of incidental lung cancers.

Melissa Lynne Johnson - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Epidemiology and survival trends of epithelial ovarian cancer (EOC) subtypes in SEER database: Time to focus on minor histologies.

Samuel Guan Wei Ow - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Ovarian cancer

N/A

The impact of sex, race, and socioeconomic status (SES) on outcomes in 6,870 patients with esophageal cancer.

Phu N. Tran - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Esophageal Cancer

N/A

Can big data tell us what clinical trials dont? Screening colonoscopy to prevent colorectal cancer in individuals aged 70-79 years.

Xabier Garcia-Albeniz - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Risk, persistence, and multiplicity of HPV infections among HIV-negative and HIV-positive Nigerian women.

Sally Nneoma Adebamowo - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Cervical cancer

N/A

Association of circulating inflammatory biomarkers and dietary inflammation potential with postmenopausal breast cancer prognosis.

Isabell Ge - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Interleukin

Filters

255783 Abstracts